Patent number: 8876761
Abstract: Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems and ingestible pills. In one embodiment, a method of producing satiety comprising the steps of accessing a gastrointestinal tract of a patient and implanting an intraintestinal therapeutic substance eluting implant. The implant is capable of eluting a satiety inducing substance selected from at least one of a nutrient, a specific satiety inducing bio-active substance, pancreatic polypeptides, free fatty acids, cholecystokinin, amino acids, glutamine, lipids, linoleic acid, or a combination thereof, from the implant into the gastrointestinal tract.
Type:
Grant
Filed:
May 10, 2011
Date of Patent:
November 4, 2014
Assignee:
Ethicon Endo-Surgery, Inc.
Inventors:
Thomas E. Albrecht, Jeffrey L. Aldridge, Sean P. Conlon, Michael S. Cropper, Denzel Z. Herrera-Davis, Daniel F. Dlugos, Jr., Jason L. Harris, Christopher J. Hess, Prasanna Malaviya, Glenda C. Marsh, Mark S. Ortiz, Mark D. Overmyer, Alessandro Pastorelli, Galen C. Robertson, Frederick E. Shelton, IV, Michael J. Stokes, James W. Voegele, Lauren S. Weaner, William B. Weisenburgh, II, Christopher W. Widenhouse, Tamara S. Vetro Widenhouse, James A. Woodard, Jr., David C. Yates, Mark S. Zeiner, Andrew M. Zwolinski
Publication number: 20140155807
Abstract: Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.
Type:
Application
Filed:
December 9, 2013
Publication date:
June 5, 2014
Applicant:
Ethicon Endo-Surgery, Inc.
Inventors:
Thomas E. Albrecht, Jeffrey L. Aldridge, Sean P. Conlon, Michael S. Cropper, Denzel Z. Herrera-Davis, Daniel F. Dlugos, Jason L. Harris, Christopher J. Hess, Thomas W. Huitema, John W. Hunt, Prasanna Malaviya, Mark S. Ortiz, Mark D. Overmyer, Alessandro Pastorelli, Galen C. Robertson, Frederick E. Shelton, IV, Michael J. Stokes, Foster B. Stulen, James W. Voegele, William B. Weisenburgh, II, Christopher W. Widenhouse, Tamara S. Vetro Widenhouse, James A. Woodard, JR., David C. Yates, Mark S. Zeiner, Andrew M. Zwolinksi
Patent number: 8636751
Abstract: Methods and devices reroute chyme to induce intestinal brake in order to improve the effectiveness of bariatric surgical procedures and to improve comorbidity resolution. A bowel is manipulated to provide a shortened path for chyme to travel to the ileum. These methods and devices of rerouting chyme to induce intestinal brake may include one or more of a surgical procedure, an implanted device, or a combination of an implant with an improved surgical procedure.
Type:
Grant
Filed:
May 10, 2011
Date of Patent:
January 28, 2014
Assignee:
Ethicon Endo-Surgery, Inc.
Inventors:
Thomas E. Albrecht, Jeffrey L. Aldridge, Sean P. Conlon, Michael S. Cropper, Denzel Z. Herrera-Davis, Daniel F. Dlugos, Jr., Jason L. Harris, Christopher J. Hess, Kevin L. Houser, Mario Gutierrez, Prasanna Malaviya, Amy L. Marcotte, Jeffrey D. Messerly, Anthony Nguyen, Mark S. Ortiz, Mark D. Overmyer, Alessandro Pastorelli, Galen C. Robertson, Frederick E. Shelton, IV, Michael J. Stokes, Foster B. Stulen, James W. Voegele, Lauren S. Weaner, Tamara S. Vetro Widenhouse, James A. Woodard, Jr., Mark S. Zeiner
Patent number: 8603023
Abstract: Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.
Type:
Grant
Filed:
May 11, 2011
Date of Patent:
December 10, 2013
Assignee:
Ethicon Endo-Surgery, Inc.
Inventors:
Thomas E. Albrecht, Jeffrey L. Aldridge, Sean P. Conlon, Michael S. Cropper, Denzel Z. Herrera-Davis, Daniel F. Dlugos, Jr., Jason L. Harris, Christopher J. Hess, Thomas W. Huitema, John V. Hunt, Prasanna Malaviya, Mark S. Ortiz, Mark D. Overmyer, Alessandro Pastorelli, Galen C. Robertson, Frederick E. Shelton, IV, Michael J. Stokes, Foster B. Stulen, James W. Voegele, William B. Weisenburgh, II, Christopher W. Widenhouse, Tamara S. Vetro Widenhouse, James A. Woodard, Jr., David C. Yates, Mark S. Zeiner, Andrew M. Zwolinski